Initial assessment of the COVID-19 vaccination's impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021.
COVID-19
health impact assessment
mass vaccination
vaccination uptake
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
entrez:
3
12
2021
pubmed:
4
12
2021
medline:
15
12
2021
Statut:
ppublish
Résumé
Prioritisation of elderly people in COVID-19 vaccination campaigns aimed at reducing severe outcomes in this group. Using EU/EEA surveillance and vaccination uptake, we estimated the risk ratio of case, hospitalisation and death notifications in people 80 years and older compared with 25-59-year-olds. Highest impact was observed for full vaccination uptake 80% or higher with reductions in notification rates of cases up to 65% (IRR: 0.35; 95% CI: 0.13-0.99), hospitalisations up to 78% (IRR: 0.22; 95% CI: 0.13-0.37) and deaths up to 84% (IRR: 0.16; 95% CI: 0.13-0.20).
Identifiants
pubmed: 34857068
doi: 10.2807/1560-7917.ES.2021.26.48.2101030
pmc: PMC8641072
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
N Engl J Med. 2021 Dec 9;385(24):e85
pubmed: 34706170
BMC Infect Dis. 2015 Oct 17;15:429
pubmed: 26474974
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156327
Euro Surveill. 2021 Jul;26(28):
pubmed: 34269175
Euro Surveill. 2021 Oct;26(41):
pubmed: 34651577
Nat Med. 2021 Dec;27(12):2108-2110
pubmed: 34728830